Shandong and Shanxi alliance cut drug prices: 50 drugs fell by more than 92%

On August 16, Shandong Province issued the "Announcement of the Lu-Jin Inter-Provincial Alliance for Drug Centralized Procurement of Drugs", officially launching the second batch of Shandong Province's centralized drug procurement work
.
On October 19, the results of the second batch of (Lu-Jin Alliance) drug centralized procurement in Shandong Province were announced
.
Among the results of this drug procurement plan, the average price of 50 drugs will be reduced by 45.
81%
.
This time, the centralized procurement of drugs is based on the implementation of the results of five batches of 218 drugs organized by the state, and the innovative implementation of the first batch of 39 drugs in the province.
The second centralized procurement of drugs in Shandong Province is also For the first time, the inter-provincial alliance took the lead in the centralized procurement of drugs
.
It is understood that this purchase selected 52 drugs that the public reported high prices, large amounts of medical institutions, and a wide range of patient audiences, covering clinical disciplines such as cardiovascular, cerebrovascular, nerve, respiratory, digestion, anti-tumor, blood, and surgery, covering The drug sales market in Shandong and Shanxi provinces has a scale of 3.
925 billion yuan
.
In this centralized procurement, a total of 284 domestic and foreign companies participated in the declaration, involving 919 products
.
Judging from the results of the proposed selection, the average price of the 50 drugs was reduced by 45.
81%, with the highest drop of 92.
74%
.
Among them, the price drop is the ozagrel sodium injection for the treatment of acute thrombotic cerebral infarction, which is reduced from 16.
52 yuan/branch to 1.
2 yuan/branch, a decrease of 92.
74%; the largest price reduction is for the treatment of varicose veins Terlipressin for injection for bleeding was reduced from 315.
8 yuan/bottle to 37.
8 yuan/bottle, and the price of a single injection was reduced by 278 yuan
.
In addition, a decline of more than 90% of the finalists as well as injection drug TMP phosphate Suzhou Erye Pharmaceutical Co.
, Ltd.
, Shenzhen Yu Han Pharmaceutical Co.
, Ltd.
injection of oxytocin
.
According to the industry, centralized procurement by volume is an important measure to control the falsely high prices and chaotic circulation of drugs and high-value medical consumables, and is a key part of comprehensively deepening the reform of centralized procurement in the pharmaceutical field
.
The substantial reduction in the purchase price of medicines will significantly reduce the burden of medical expenses for the masses
.
This time the Lu-Jin alliance gathered, patients in Shandong and Shanxi provinces will soon use the reduced-price medicines
.
In addition, according to relevant sources, in order to improve the supply of drugs that are prone to shortages and better meet the needs of people's health and clinical rational use of drugs, this batch of centralized procurement has made a series of measures to ensure the supply of drugs that are prone to shortages
.
If the number of selected companies is increased, the number of selected companies will be expanded for the medicines that are subject to shortage in this centralized procurement
.
"We insist that multiple companies are selected.
Four companies can be selected under the same generic name for commonly used drugs, and there can be up to six drugs that are easy to be in short supply.
This makes the bidding of the winning company more rational and the price is more reasonable
.
" The person said
.
At the same time, this centralized procurement also paid more attention to the quality of selected drugs
.
Such as insisting on group competition
.
For the drugs of each declared enterprise within the same variety, full consideration of factors such as quality and efficacy differences, the patent drugs that have passed the protection period, reference preparations, and drugs that have passed the consistency evaluation (including deemed equivalent) are listed as the first review group to ensure Drugs of the same quality level compete fairly on the same platform
.
Analysts said that centralized drug procurement has become normal, and this time, Shandong and Shanxi formed an inter-provincial alliance, which played an important role in the expansion of the market and the further improvement of enterprises' participation enthusiasm
.